Stephanie Alband will begin her two-year term as President of the International Neuroendocrine Cancer Alliance (INCA). Pheo Para Alliance is one of 37 patient advocacy organizations that are a part of INCA. INCA serves as the global voice for patients with neuroendocrine cancer and genetic neuroendocrine tumors (NETs) and their carers with a mission to raise awareness about all types of NETs, push for scientific advancements with a focus on identified unmet needs and provide a platform for global collaboration to address the many challenges patients and the medical community face, in securing a timely diagnosis and accessing optimal treatment, support and care.
Stephanie has previously served on the INCA Board of Directors and as Chair of the Communications Committee which leads NET Cancer Day. Stephanie states, “It is an honor and privilege to represent the collective voice of 37 patient advocacy organizations globally. Because of the tireless work of these organizations, NETS are not considered as rare as they were once believed to be. This role also provides an opportunity to ensure lesser-known NETS, such as pheo para, and genetic NETS are accurately represented.”